Comprehensive approaches encompassing antibiotic stewardship, microbiome restoration, and nanotechnology integration with AMPs, bacteriophages, and alternative therapeutic agents are essential for addressing the multifaceted challenges posed by respiratory tract infections and their resistance mechanisms and moving toward precision medicine. Here, ADSL is linked to Respiratory tract infection.